Fikri Başlamıslı

760 total citations
24 papers, 537 citations indexed

About

Fikri Başlamıslı is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Fikri Başlamıslı has authored 24 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 8 papers in Genetics and 4 papers in Molecular Biology. Recurrent topics in Fikri Başlamıslı's work include Hemoglobinopathies and Related Disorders (6 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and Blood groups and transfusion (3 papers). Fikri Başlamıslı is often cited by papers focused on Hemoglobinopathies and Related Disorders (6 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and Blood groups and transfusion (3 papers). Fikri Başlamıslı collaborates with scholars based in Türkiye and United States. Fikri Başlamıslı's co-authors include Semra Paydaş, Kahraman Tanrıverdi, Suzan Zorludemir, Emel Gürkan, Sinan Yavuz, Melek Ergin, Fılız Bolat, Berksoy Şahin, Birol Güvenç and Umut Dişel and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Clinical Microbiology and Journal of Clinical Pathology.

In The Last Decade

Fikri Başlamıslı

24 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fikri Başlamıslı Türkiye 14 233 131 90 72 69 24 537
Konstantinos Anargyrou Greece 15 284 1.2× 110 0.8× 157 1.7× 17 0.2× 63 0.9× 28 648
Vildan Özkocaman Türkiye 14 186 0.8× 86 0.7× 109 1.2× 18 0.3× 49 0.7× 56 601
J. H. Robertson United Kingdom 17 85 0.4× 86 0.7× 65 0.7× 25 0.3× 72 1.0× 38 748
F J Barbado Spain 15 85 0.4× 31 0.2× 51 0.6× 24 0.3× 65 0.9× 27 567
Ruth E. Luddy United States 12 229 1.0× 170 1.3× 46 0.5× 9 0.1× 65 0.9× 18 511
Ahmet Tunalı Türkiye 11 166 0.7× 55 0.4× 83 0.9× 16 0.2× 27 0.4× 22 440
Feride Duru Türkiye 15 262 1.1× 189 1.4× 39 0.4× 7 0.1× 59 0.9× 41 670
Peter B. Neame Canada 10 288 1.2× 67 0.5× 56 0.6× 7 0.1× 122 1.8× 19 541
Ellen Klapper United States 16 349 1.5× 124 0.9× 19 0.2× 9 0.1× 158 2.3× 47 803
Davut Albayrak Türkiye 15 201 0.9× 72 0.5× 88 1.0× 6 0.1× 47 0.7× 62 579

Countries citing papers authored by Fikri Başlamıslı

Since Specialization
Citations

This map shows the geographic impact of Fikri Başlamıslı's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fikri Başlamıslı with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fikri Başlamıslı more than expected).

Fields of papers citing papers by Fikri Başlamıslı

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fikri Başlamıslı. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fikri Başlamıslı. The network helps show where Fikri Başlamıslı may publish in the future.

Co-authorship network of co-authors of Fikri Başlamıslı

This figure shows the co-authorship network connecting the top 25 collaborators of Fikri Başlamıslı. A scholar is included among the top collaborators of Fikri Başlamıslı based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fikri Başlamıslı. Fikri Başlamıslı is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Paydaş, Saime, Semra Paydaş, Mustafa Balal, et al.. (2013). Late Onset Epstein Barr Virus Seropositive Posttransplant Lymphoproliferative Disorder in Two Renal Transplant Receivers. SHILAP Revista de lepidopterología. 30(3). 315–320. 1 indexed citations
2.
Kanadaşı, Mehmet, et al.. (2007). Tissue Doppler imaging and NT-proBNP levels show the early impairment of ventricular function in patients with ß-thalassaemia major. Acta Cardiologica. 62(3). 221–223. 15 indexed citations
3.
Paydaş, Saime, Mustafa Balal, Kahraman Tanrıverdi, Yaşar Sertdemır, & Fikri Başlamıslı. (2007). The Relationship between the VEGF Levels and VEGF mRNA Expression and Clinical Course in Different Glomerulonephritis. Renal Failure. 29(7). 779–784. 7 indexed citations
4.
Oto, Özgür Akın, Semra Paydaş, Fikri Başlamıslı, et al.. (2006). Transfusion-associated graft-versus-host disease. European Journal of Internal Medicine. 17(3). 151–156. 5 indexed citations
5.
Gürkan, Emel, Kahraman Tanrıverdi, & Fikri Başlamıslı. (2005). Telomerase activity in myelodysplastic syndromes. Leukemia Research. 29(10). 1131–1139. 27 indexed citations
6.
Gürkan, Emel, et al.. (2005). Thrombotic thrombocytopenic purpura in southern Turkey: a single-center experience of 29 cases. Clinical & Laboratory Haematology. 27(2). 121–125. 13 indexed citations
7.
Gürkan, Emel, et al.. (2005). Liver involvement in sickle cell disease.. PubMed. 16(4). 194–8. 15 indexed citations
8.
Paydaş, Semra, Kahraman Tanrıverdi, Sinan Yavuz, et al.. (2005). PRAME mRNA levels in cases with acute leukemia: Clinical importance and future prospects. American Journal of Hematology. 79(4). 257–261. 54 indexed citations
9.
Gürkan, Emel, Kahraman Tanrıverdi, & Fikri Başlamıslı. (2004). Clinical relevance of vascular endothelial growth factor levels in sickle cell disease. Annals of Hematology. 84(2). 71–75. 18 indexed citations
10.
Gürkan, Emel, et al.. (2004). Budd-Chiari Syndrome Associated with Visceral Leishmaniasis and Factor V Leiden Mutation. Journal of Thrombosis and Thrombolysis. 18(3). 205–207. 2 indexed citations
11.
Kanadaşı, Mehmet, Kahraman Tanrıverdi, Mesut Demir, et al.. (2004). Prothrombin 20210GA and Factor V Leiden Mutations in Patients Less Than 55 Years Old With Myocardial Infarction. Japanese Heart Journal. 45(3). 505–512. 29 indexed citations
12.
Gürkan, Emel, et al.. (2003). Immune thrombocytopenic purpura associated with Brucella and Toxoplasma infections. American Journal of Hematology. 74(1). 52–54. 13 indexed citations
13.
Canataroğlu, Abdullah, Kahraman Tanrıverdi, Tamer İnal, et al.. (2003). Methylenetetrahydrofolate reductase gene C677T mutation and plasma homocysteine level in Beh�et's disease. Rheumatology International. 23(5). 236–240. 30 indexed citations
14.
Paydaş, Semra, Melek Ergin, Fikri Başlamıslı, et al.. (2002). Bone marrow necrosis: Clinicopathologic analysis of 20 cases and review of the literature. American Journal of Hematology. 70(4). 300–305. 97 indexed citations
15.
Paydaş, Semra, Suzan Zorludemir, Fikri Başlamıslı, & İlhan Tuncer. (2002). Vascular Endothelial Growth Factor (VEGF) Expression in Plasmacytoma. Leukemia & lymphoma. 43(1). 139–143. 12 indexed citations
16.
Tamer, Lülüfer, et al.. (2002). Levels of malondialdehyde, glutathione and ascorbic acid in idiopathic thrombocytopaenic purpura. East African Medical Journal. 79(8). 446–9. 21 indexed citations
17.
Güvenç, Birol, et al.. (2001). Value of duplex and color doppler ultrasonography in the evaluation of orbital vascular flow and resistance in sickle cell disease. American Journal of Hematology. 67(3). 163–167. 21 indexed citations
18.
Gökel, Yüksel, et al.. (1997). Çukurova yöresinde yılan ısırmaları. Cukurova Medical Journal (Çukurova Üniversitesi Tıp Fakültesi Dergisi). 22(3). 184–188. 1 indexed citations
19.
Güvenç, Birol, et al.. (1996). Spectral pulsed Doppler sonography of renal vascular resistance in sickle cell disease: clinical implications. British Journal of Radiology. 69(828). 1125–1129. 8 indexed citations
20.
Alparslan, Z. Nazan, et al.. (1995). The frequency of anaemia, iron deficiency, hemoglobin S and beta thalassemia in the South of Turkey. European Journal of Epidemiology. 11(2). 181–184. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Konstantinos Anargyrou Breakdown of academic impact, for papers by Vildan Özkocaman Breakdown of academic impact, for papers by J. H. Robertson Breakdown of academic impact, for papers by F J Barbado Breakdown of academic impact, for papers by Ruth E. Luddy Breakdown of academic impact, for papers by Ahmet Tunalı Breakdown of academic impact, for papers by Feride Duru Breakdown of academic impact, for papers by Peter B. Neame Breakdown of academic impact, for papers by Ellen Klapper Breakdown of academic impact, for papers by Davut Albayrak
Rankless by CCL
2026